| 1 | (1-13C) Sodium Acetate | [2] Acetate Acetate, Sodium acetate | [1] Sodium acetate
Sodium acetate
💬
| - | - | [1] 251 251 💬
|
| 2 | 15N ammonium chloride (15NH4Cl) | [1] Ammonium chloride Ammonium chloride | [1] Ammonium chloride
Ammonium chloride
💬
| - | - | [1] 251 251 💬
|
| 3 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 4 | [nd] | - | - | - | - | [1] 251 251 💬
|
| 5 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 6 | Acetohydroxamic Acid | [1] Acetohydroxamic acid Acetohydroxamic acid | [1] Acetohydroxamic acid
Acetohydroxamic acid
💬
| - | - | [1] 251 251 💬
|
| 7 | Acetohydroxamic Acid Oral Tablet [Lithostat] | [1] Acetohydroxamic acid Acetohydroxamic acid | [1] Acetohydroxamic acid
Acetohydroxamic acid
💬
| - | - | [1] 251 251 💬
|
| 8 | Alanine | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [8] 6 6, 13, 70, 94, 97, 251, 298, 299 💬
|
| 9 | ALLOGENIC HUMAN HETEROLOGOUS LIVER CELLS | - | - | - | - | [1] 251 251 💬
|
| 10 | Ammonia | [1] Ammonia Ammonia | [1] Ammonia solution, strong
Ammonia solution, strong
💬
| - | - | [6] 6 6, 17, 86, 88, 251, 296 💬
|
| 11 | Ammonium (15N) chloride | - | - | - | - | [1] 251 251 💬
|
| 12 | Ammonium chloride | [1] Ammonium chloride Ammonium chloride | [1] Ammonium chloride
Ammonium chloride
💬
| - | - | [3] 96 96, 107, 251 💬
|
| 13 | ARCT-810 | [1] ARCT-810 ARCT-810 | - | - | - | [1] 251 251 💬
|
| 14 | ARCT-810Product Code: [ARCT-810]Pharmaceutical Form: Concentrate for solution for injection/infusionCurrent Sponsor code: ARCT-810Other descriptive name: mRNA codificante per Ornitina transcarbamilasi modificataConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 1-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous useProduct Name: Acetato di sodio (1,2-13C2)Product Code: [Non Applicabile]Pharmaceutical Form: Powder for oral solutionCAS Number: 56374-56-2Current Sponsor code: Acetato di sodio (1,2-13C2)Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 250- | [1] ARCT-810 ARCT-810 | - | - | - | [1] 251 251 💬
|
| 15 | Arginine | [1] Arginine Arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [16] 2 2, 21, 46, 57, 58, 67, 72, 96, 97, 98, 113, 210, 223, 225, 251, 299 💬
|
| 16 | Avalotcagene ontaparvovec | [1] Avalotcagene ontaparvovec Avalotcagene ontaparvovec | - | - | - | [1] 251 251 💬
|
| 17 | Behavioral: Protein and calorie controlled diet | - | - | - | - | [1] 251 251 💬
|
| 18 | Carglumic Acid | [1] Carglumic acid Carglumic acid | [1] Carglumic acid
Carglumic acid
💬
| [1] CPS1 CPS1 💬
| [3] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬 | [3] 245 245, 246, 251 💬
|
| 19 | Celulas hepatocitos troncales adultas alogenicas de higado expandidas | - | - | - | - | [1] 251 251 💬
|
| 20 | CMP-CPS-001 | - | - | - | - | [1] 251 251 💬
|
| 21 | Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8 Days - 7 Years | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 22 | Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8-18 Years | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 23 | Diagnostic Test: Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 24 | Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 - 18 years) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 25 | Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 Days- 7 years) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 26 | Diagnostic Test: Obtaining Dry Blood Spots From High-risk Newborns (Aged 1-7 Days) | - | - | - | - | [10] 244 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
|
| 27 | Diagnostic Test: Urea cycle flux study | [1] Urea Urea | [2] Urea
Urea
,
Urea C13
💬
| - | - | [1] 251 251 💬
|
| 28 | DTX301 | [1] Avalotcagene ontaparvovec Avalotcagene ontaparvovec | - | - | - | [1] 251 251 💬
|
| 29 | Genetic: AAVLK03hOTC | - | - | - | - | [1] 251 251 💬
|
| 30 | Genetic: Adenoviral Vector-Mediated Gene Transfer | - | - | - | - | [1] 251 251 💬
|
| 31 | Genetic: DTX301 | - | - | - | - | [1] 251 251 💬
|
| 32 | Genetic: ECUR-506 | - | - | - | - | [1] 251 251 💬
|
| 33 | Genetic: Ornithine transcarbamylase vector | [1] Ornithine Ornithine | [2] Ornithine
Ornithine
,
Ornithine aspartate
💬
| - | - | [1] 251 251 💬
|
| 34 | Genetic: recombinant adenovirus containing the ornithine transcarbamylase gene | [1] Ornithine Ornithine | [2] Ornithine
Ornithine
,
Ornithine aspartate
💬
| - | - | [1] 251 251 💬
|
| 35 | Genetic: scAAV8OTC | - | - | - | - | [1] 251 251 💬
|
| 36 | Glyceryl tri-(4-phenylbutyrate) | - | - | - | - | [1] 251 251 💬
|
| 37 | Glyceryl tri-(4-phenylbutyrate)(GT4P) | - | - | - | - | [1] 251 251 💬
|
| 38 | Heparesc | - | - | - | - | [1] 251 251 💬
|
| 39 | HepaStem | - | - | - | - | [1] 251 251 💬
|
| 40 | HepaStem Infusion | - | - | - | - | [1] 251 251 💬
|
| 41 | Heterologous Human Adult Liver-derived Progenitor Cells | - | - | - | - | [1] 251 251 💬
|
| 42 | Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC) | - | - | - | - | [1] 251 251 💬
|
| 43 | HHALPC | - | - | - | - | [1] 251 251 💬
|
| 44 | HHLivC | - | - | - | - | [1] 251 251 💬
|
| 45 | HPN-100 | - | - | - | - | [1] 251 251 💬
|
| 46 | Human Heterologous Liver Cells | - | - | - | - | [1] 251 251 💬
|
| 47 | Human heterologous liver cells (for infusion) | - | - | - | - | [1] 251 251 💬
|
| 48 | Isotopic Intravenous [13C]-Urea | [1] Urea Urea | [2] Urea
Urea
,
Urea C13
💬
| - | - | [1] 251 251 💬
|
| 49 | KB195 | - | - | - | - | [1] 251 251 💬
|
| 50 | MRNA encoding modified Ornithine transcarbamylase | [1] Ornithine Ornithine | [2] Ornithine
Ornithine
,
Ornithine aspartate
💬
| - | - | [1] 251 251 💬
|
| 51 | MRT5201 | [1] MRT5201 MRT5201 | - | - | - | [1] 251 251 💬
|
| 52 | NaPBA | - | - | - | - | [1] 251 251 💬
|
| 53 | Neo-ASA | - | - | - | - | [1] 251 251 💬
|
| 54 | Nitric Oxide | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [12] 46 46, 51, 85, 86, 88, 97, 98, 210, 251, 294, 299, 340 💬
|
| 55 | Nitric oxide supplement | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 251 251 💬
|
| 56 | Oral corticosteroids | - | - | - | - | [4] 13 13, 46, 97, 251 💬
|
| 57 | Ornithine | [1] Ornithine Ornithine | [2] Ornithine
Ornithine
,
Ornithine aspartate
💬
| - | - | [3] 96 96, 245, 251 💬
|
| 58 | Other: Aminoacid, alanine-infusion | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [1] 251 251 💬
|
| 59 | Prednisolon | - | - | - | - | [11] 46 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
|
| 60 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 61 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 62 | Promethera HepaStem | - | - | - | - | [1] 251 251 💬
|
| 63 | Prophylactic Corticosteroid Taper Regimen | - | - | - | - | [1] 251 251 💬
|
| 64 | RAVICTI | - | - | - | - | [2] 7 7, 251 💬
|
| 65 | Reactive Corticosteroid Taper Regimen | - | - | - | - | [1] 251 251 💬
|
| 66 | Sodium acetate | [2] Acetate Acetate, Sodium acetate | [1] Sodium acetate
Sodium acetate
💬
| - | - | [2] 81 81, 251 💬
|
| 67 | Sodium acetate (1-13C) | [2] Acetate Acetate, Sodium acetate | [1] Sodium acetate
Sodium acetate
💬
| - | - | [1] 251 251 💬
|
| 68 | Sodium Ethanoate (1- 13 C) | - | - | - | - | [1] 251 251 💬
|
| 69 | Sodium Ethanoate (1-13C) | - | - | - | - | [1] 251 251 💬
|
| 70 | Sodium phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | [1] Sodium phenylbutyrate
Sodium phenylbutyrate
💬
| - | - | [5] 2 2, 3, 8, 18, 251 💬
|
| 71 | SYNB1020 | [1] SYNB1020 SYNB1020 | - | - | - | [1] 251 251 💬
|
| 72 | Urea | [1] Urea Urea | [2] Urea
Urea
,
Urea C13
💬
| - | - | [2] 72 72, 251 💬
|